Compounds > 2',3'-dideoxy-beta-5-fluorocytidine

Page last updated: 2024-08-25

2',3'-dideoxy-beta-5-fluorocytidine and HIV

2',3'-dideoxy-beta-5-fluorocytidine has been researched along with HIV in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (16.67)	18.7374
1990's	5 (83.33)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Broder, S; Driscoll, JS; Kim, CH; Marquez, VE; Mitsuya, H	1
Cheng, YC; Dutschman, GE; Gullen, E; Lin, TS; Liu, MC; Luo, MZ; Zhu, YL	1
Chen, SH; Cheng, YC; Doyle, TW; Dutschman, GE; Gullen, EA; King, I; Mao, J; Wang, Q	1
Ashman, C; Barbeau, D; Cammack, N; Duchaine, J; Gagnon, L; Hamel, M; Hooker, E; Jutras, D; Nordstrom, PA; Tse, A	1
Aubertin, AM; Bergogne, MC; Gosselin, G; Imbach, JL; Kirn, A; Mathé, C; Schinazi, RF; Sommadossi, JP	2

Other Studies

6 other study(ies) available for 2',3'-dideoxy-beta-5-fluorocytidine and HIV

Article	Year
Potential anti-AIDS drugs. 2',3'-Dideoxycytidine analogues. Journal of medicinal chemistry, 1987, Volume: 30, Issue:5 Topics: Acquired Immunodeficiency Syndrome; Cell Line; Chemical Phenomena; Chemistry; Deoxycytidine; HIV; Structure-Activity Relationship; T-Lymphocytes, Helper-Inducer; Zalcitabine	1987
Design and synthesis of 2',3'-dideoxy-2',3'-didehydro-beta-L-cytidine (beta-L-d4C) and 2',3'-dideoxy 2',3'-didehydro-beta-L-5-fluorocytidine (beta-L-Fd4C), two exceptionally potent inhibitors of human hepatitis B virus (HBV) and potent inhibitors of human Journal of medicinal chemistry, 1996, Apr-26, Volume: 39, Issue:9 Topics: Antiviral Agents; Drug Design; Hepatitis B virus; HIV; Humans; Zalcitabine	1996
Synthesis and biological evaluation of a series of 2'-fluorinated-2',3'-dideoxy-2',3'-didehydro-(L)-nucleosides. Bioorganic & medicinal chemistry letters, 1998, Jul-07, Volume: 8, Issue:13 Topics: Antiviral Agents; Cell Line; Dideoxynucleosides; Fluorine; Hepatitis B virus; HIV; Humans	1998
Immunomodulatory and antiviral activities of 2',3'-dideoxy-beta-L-cytidine and 2',3'-dideoxy-beta-L-5-fluorocytidine. Immunopharmacology and immunotoxicology, 1995, Volume: 17, Issue:1 Topics: Animals; Antiviral Agents; Cell Cycle; Cell Line; Chlorocebus aethiops; Hepatitis B virus; HIV; Humans; Immunosuppressive Agents; Lymphocyte Activation; Mice; Simplexvirus; T-Lymphocytes; Tumor Cells, Cultured; Vero Cells; Zalcitabine	1995
Enantiomeric 2',3'-dideoxycytidine derivatives are potent human immunodeficiency virus inhibitors in cell cultures. Comptes rendus de l'Academie des sciences. Serie III, Sciences de la vie, 1994, Volume: 317, Issue:1 Topics: Cells, Cultured; HIV; HIV-1; HIV-2; Molecular Conformation; Stereoisomerism; Zalcitabine	1994
Anti-human immunodeficiency virus activities of the beta-L enantiomer of 2',3'-dideoxycytidine and its 5-fluoro derivative in vitro. Antimicrobial agents and chemotherapy, 1994, Volume: 38, Issue:6 Topics: Antiviral Agents; Bone Marrow; Cell Line; Drug Resistance; HIV; Humans; Stereoisomerism; Zalcitabine	1994